• No results found

University of Groningen Testicular cancer: diagnostic and surgical strategies to improve outcome Ozturk, Cigdem

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Testicular cancer: diagnostic and surgical strategies to improve outcome Ozturk, Cigdem"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Testicular cancer: diagnostic and surgical strategies to improve outcome

Ozturk, Cigdem

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Ozturk, C. (2018). Testicular cancer: diagnostic and surgical strategies to improve outcome. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op maandag 26 november 2018 om 12.45 uur

door

Çiğdem Öztürk

geboren op 15 mei 1981

te ‘s-Gravenhage

Cover Design & Layout

Fleur Bominaar, FYN Werk www.fynwerk.nl

Printed by

Gildeprint, Enschede www.gildeprint.nl

ISBN: 978-94-034-0895-8 (printed version) ISBN: 978-94-034-0894-1 (electronic version) © 2018 Ç. Öztürk, The Netherlands

All rights reserved. No part of this book may be reproduced, stored in a retreival system or transmitted in any form or by any means, without prior permission of the author.

For printing of this thesis, financial support of the following institutions and companies is gratefully acknowledged:

• • Pfizer

• KARL STORZ Endoscopie Nederland B.V. • Erbe Nederland B.V.

• Noord Negentig accountants en belastingadviseurs • Stichting Werkgroep Interne Oncologie

• Research Institute Guide • Heelkunde Friesland

(3)

Promotores

Prof. dr. H.J. Hoekstra Prof. dr. J.A. Gietema

Copromotor

Dr. R.J. van Ginkel

Beoordelingscommissie

Prof. dr. T.M. de Reijke Prof. dr. S. Horenblas Prof. dr. A.J.H. Suurmeijer

Introduction 7

General introduction 9

Aims and research questions of this thesis 25 Delay in diagnosis of testicular cancer; a need for 31

awareness programs

PLoS One. 2015 Nov 25;10(11): e0141244

Assessment of volumetric versus manual measurement in 47 disseminated testicular cancer; no difference in assessment

between non-radiologists and genitourinary radiologist PLoS One. 2017 Jan 12;12(1): e0168977

Laparoscopic resection of a residual retroperitoneal tumor 65 mass of nonseminomatous testicular germ cell tumors

Surgical Endoscopy and Other Interventional Techniques 2012; 26: 458-167 Laparoscopic resection of residual retroperitoneal tumor mass in 83

advanced nonseminomatous testicular germ cell tumors; a feasible and safe oncological procedure

Scientific Reports. Submitted September 2018

Posterior retroperitoneoscopic approach in the setting of a prior 105 resection of residual retroperitoneal tumor mass in advanced

nonseminomatous testicular germ cell tumor: a case report of this alternative surgical approach.

BMJ Case Reports. Submitted September 2018

Future perspectives 117

Summary 125

Samenvatting 133

Appendix 141

Historical overview of testicular cancer treatment at the UMCG

Dankwoord 152

Curriculum Vitae 163

Referenties

GERELATEERDE DOCUMENTEN

(A- C) Mean percentage of apoptotic and death cells and WB using 833KE, Tera and NCCIT treated with AZD8055 and MLN0128 and/or cisplatin.. Data shows average and ± SD of

Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German

Both actions, education of adolescent and young adult men and of GP’s to increase knowledge and awareness of testicular cancer, and continuous medical education of GPs with respect

The aim of this study was to assess the feasibility and reproducibility of semi-automatic volumetric measurement of retroperitoneal lymph node metastases in testicular cancer

Resection of a residual retroperitoneal tumor mass (RRRTM) is standard procedure after combination chemotherapy for metastatic nonseminomatous testicular germ cell tumors

To describe the 10 year experience and oncological results of the University Medical Center Groningen with conventional laparotomy (C-RRRTM) and laparoscopy (L-RRRTM) to

Treatment of stage II-IV nonseminomatous testicular germ cell tumors (NSTGCT) consists of cisplatin based combination chemotherapy and, when present, resection of residual

119 Today, with the high cure rates presented for disseminated testicular cancer (TC) after treatment with cisplatin based combination chemotherapy, higher than for any